➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Harvard Business School
Colorcon
AstraZeneca
Moodys

Last Updated: January 23, 2021

DrugPatentWatch Database Preview

Litigation Details for CITY OF PROVIDENCE v. CELGENE CORPORATION (D.N.J. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

CITY OF PROVIDENCE v. CELGENE CORPORATION (D.N.J. 2015)

Docket   Start Trial Date Filed 2015-03-03
Court District Court, D. New Jersey Date Terminated 2015-03-31
Cause 15:25 Clayton Act Assigned To Madeline Cox Arleo
Jury Demand Plaintiff Referred To Leda Dunn Wettre
Parties CELGENE CORPORATION; CITY OF PROVIDENCE
Patents 6,045,501; 6,281,230; 6,315,720; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 7,119,106; 7,465,800; 8,288,415; 8,315,886; 8,404,717
Attorneys JENNIFER SARNELLI
Firms Gardy & Notis, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in CITY OF PROVIDENCE v. CELGENE CORPORATION
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for CITY OF PROVIDENCE v. CELGENE CORPORATION (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-03-03 1 . Celgene’s patents on the procedures for safe distribution include the 6,045,501 patent, the 6,315,720… Obtained 6,045,501501 patent Methods for delivering a 8/28/1998 …,720 patent, the 6,561,976 patent, the 6,561,977 patent and the 6,755,784 patent (the “Distribution Method…information describing the patent as a “drug product patent” only if the patent claimed the specific drug… Method Patents”), and the 8,315,886 patent. Specifically, these patents claim the following subject External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Merck
Colorcon
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.